Which has the lower trailing P/E, DXCM or RMD?

RMD has the lower trailing P/E: DXCM trades at 33.50 and RMD at 20.92. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or RMD?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus RMD at 12.08%.

Does DXCM or RMD pay a bigger dividend?

RMD pays a dividend (1.13% yield), while DXCM has no payments in the available dividend history.

Is DXCM or RMD more profitable?

RMD runs the higher net margin — DXCM at 20.12% versus RMD at 26.94%.

How have DXCM and RMD total returns compared?

Over the past 10 years, DXCM delivered 14.02% and RMD delivered 13.01% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs ResMed Inc. (RMD)

A side-by-side comparison of DexCom, Inc. and ResMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$33.06B

$87.62HealthcareDelayed quote: Aug 10, 2026, 12:20 PM EDT

RMD

ResMed Inc.

$31.83B

$219.45HealthcareDelayed quote: Aug 10, 2026, 12:20 PM EDT

Total return — DXCM vs RMD

growth of $100 · dividends reinvested · last 10y

DXCM +272.0% (+14.0%/yr)RMD +242.1% (+13.1%/yr)DXCM compounded faster over this window

DXCM RMD

DXCM vs RMD: by the numbers

•DXCM is the larger company ($33.06B vs $31.83B market cap).
•RMD trades at the lower trailing earnings multiple (20.92 vs 33.50 P/E), one valuation lens rather than an overall verdict.
•RMD converts more revenue to profit (26.94% vs 20.12% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 12.08% CAGR).
•RMD pays a dividend (1.13% yield), while DXCM has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DXCM	RMD
P/E ratio	33.50	20.92
Forward P/E	31.89	19.05
P/S ratio	6.68	5.95
P/B ratio	12.67	5.07
EV / EBITDA	23.87	14.93
FCF yield	4.23%	5.31%

Profitability

Metric	DXCM	RMD
Gross margin	62.47%	61.06%
Operating margin	22.92%	33.48%
Net margin	20.12%	26.94%
ROE	38.14%	23.13%
ROIC	16.61%	19.05%

Dividends

Metric	DXCM	RMD
Dividend yield	N/A	1.13%

Growth (annualized)

Metric	DXCM	RMD
Revenue CAGR (5Y)	18.03%	12.08%
EPS CAGR (5Y)	10.31%	N/A
FCF CAGR (5Y)	69.49%	36.06%
Total return CAGR (5Y)	-8.08%	-4.21%

Frequently asked

Which has the lower trailing P/E, DXCM or RMD?: RMD has the lower trailing P/E: DXCM trades at 33.50 and RMD at 20.92. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or RMD?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus RMD at 12.08%.
Does DXCM or RMD pay a bigger dividend?: RMD pays a dividend (1.13% yield), while DXCM has no payments in the available dividend history.
Is DXCM or RMD more profitable?: RMD runs the higher net margin — DXCM at 20.12% versus RMD at 26.94%.
How have DXCM and RMD total returns compared?: Over the past 10 years, DXCM delivered 14.02% and RMD delivered 13.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full RMD analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio ResMed P/E ratio ResMed dividend yield DexCom ROE ResMed ROE DexCom operating margin ResMed operating margin DexCom revenue growth ResMed revenue growth DexCom free cash flow ResMed free cash flow

DexCom & ResMed appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.